Insulin and neurodegenerative disease: shared and specific mechanisms

Insulin has functions in the brain and dysregulation of these functions may contribute to the expression of late-life neurodegenerative disease. We provide a brief summary of research on the influence of insulin on normal brain function. We then review evidence that perturbation of this role may contribute to the symptoms and pathogenesis of various neurodegenerative disorders, such as Alzheimer's disease, vascular dementia, Parkinson's disease, and Huntington's disease. We conclude by considering whether insulin dysregulation contributes to neurodegenerative disorders through disease-specific or general mechanisms.

[1]  D. Porte,et al.  Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats , 1990, Peptides.

[2]  R. D'Agostino,et al.  NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study , 1997, Diabetes Care.

[3]  C. Livingstone,et al.  Hypothalamic GLUT 4 expression: a glucose- and insulin-sensing mechanism? , 1995, Molecular and Cellular Endocrinology.

[4]  H. Kaffarnik,et al.  [Fatty acid patterns and glucose tolerance in Huntington's chorea (author's transl)]. , 1976, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[5]  George A. Carlson,et al.  The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[6]  Brett Chromy,et al.  Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus , 2002, Brain Research.

[7]  A. Hofman,et al.  Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .

[8]  L. Sokoloff,et al.  Effects of Insulin on Local Cerebral Glucose Utilization in the Rat , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  A. Korczyn,et al.  Risk factors for dementia in Parkinson's disease. , 1990, Advances in neurology.

[10]  G. Reaven,et al.  Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? , 2000, Free radical biology & medicine.

[11]  S. Hoyer,et al.  The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review , 2002, Journal of Neural Transmission.

[12]  L. Axelrod.  Insulin, Prostaglandins, and the Pathogenesis of Hypertension , 1991, Diabetes.

[13]  R. Schliebs,et al.  Insulin‐sensitive GLUT4 glucose transporters are colocalized with GLUT3‐expressing cells and demonstrate a chemically distinct neuron‐specific localization in rat brain , 1999, Journal of neuroscience research.

[14]  K. Jellinger,et al.  Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.

[15]  T. Videen,et al.  Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. , 1998, Diabetes.

[16]  S. Woods,et al.  Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra , 1994, Brain Research.

[17]  M. Uldry,et al.  GLUTX1, a Novel Mammalian Glucose Transporter Expressed in the Central Nervous System and Insulin-sensitive Tissues* , 2000, The Journal of Biological Chemistry.

[18]  L. Pénicaud,et al.  Effects of hyperinsulinemia on local cerebral insulin binding and glucose utilization in normoglycemic awake rats , 1990, Neuroscience Letters.

[19]  R. Havlik,et al.  Characterization of risk factors for vascular dementia , 1999, Neurology.

[20]  G. Zuliani,et al.  Alzheimer Disease and Vascular Dementia: Relationships with Fasting Glucose and Insulin Levels , 2000, Dementia and Geriatric Cognitive Disorders.

[21]  J. Allum,et al.  The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism , 2003, Neurology.

[22]  M. Kearney,et al.  Pathophysiological implications of insulin resistance on vascular endothelial function , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[23]  R Sandyk,et al.  The relationship between diabetes mellitus and Parkinson's disease. , 1993, The International journal of neuroscience.

[24]  Johanna Kuusisto,et al.  Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study , 1997, BMJ.

[25]  Huaxi Xu,et al.  Potential roles of insulin and IGF-1 in Alzheimer's disease , 2003, Trends in Neurosciences.

[26]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[27]  R. Nusse,et al.  Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes , 2002, Science.

[28]  J. Kushner,et al.  Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation , 2003, The Journal of Neuroscience.

[29]  M. Bennett,et al.  Insulin promotes rapid delivery of N-methyl-d- aspartate receptors to the cell surface by exocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Sirtori,et al.  Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. , 1972, The New England journal of medicine.

[31]  C. Viscoli,et al.  Insulin resistance and risk for stroke , 2002, Neurology.

[32]  G. Milligan,et al.  Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. , 1993, Biochemical and biophysical research communications.

[33]  R. Mayeux,et al.  Hyperinsulinemia and risk of Alzheimer disease , 2004, Neurology.

[34]  J. Cresto,et al.  Degradation of Soluble Amyloid β-Peptides 1–40, 1–42, and the Dutch Variant 1–40Q by Insulin Degrading Enzyme from Alzheimer Disease and Control Brains , 2000, Neurochemical Research.

[35]  R. Sandyk,et al.  The association of diabetes mellitus with dementia in Parkinson's disease. , 1992, The International journal of neuroscience.

[36]  W. Jagust,et al.  Prevalence of Dementia in Older Latinos: The Influence of Type 2 Diabetes Mellitus, Stroke and Genetic Factors , 2003, Journal of the American Geriatrics Society.

[37]  V. Lee,et al.  Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons* , 1997, The Journal of Biological Chemistry.

[38]  M. Owen,et al.  Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease , 2001, Human Genetics.

[39]  G. Mcclearn,et al.  Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer's Disease: A Population-Based Study of the Oldest Old , 2002, International Psychogeriatrics.

[40]  L. Niskanen,et al.  Short-Term and Long-Term Memory in Elderly Patients with NIDDM , 1995, Diabetes Care.

[41]  H. Soininen,et al.  Type‐2 diabetes and cognitive function in a non‐demented population , 1999, Acta neurologica Scandinavica.

[42]  R. Barker,et al.  Vascular Parkinsonism: A Review of the Precision and Frequency of the Diagnosis , 2001, Neuroepidemiology.

[43]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[44]  Hiroshi Kimura,et al.  Insulin receptor mRNA in the substantia nigra in Parkinson's disease , 1996, Neuroscience Letters.

[45]  K. Butcher,et al.  The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome , 2002, Journal of Clinical Neuroscience.

[46]  E. Anggard,et al.  F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. , 1999, European journal of pharmacology.

[47]  L. Hernández,et al.  Diabetes decreases limbic extracellular dopamine in rats , 1996, Neuroscience Letters.

[48]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[49]  J. Livingston,et al.  Insulin receptors in the central nervous system: Localization, signalling mechanisms and functional aspects , 1991, Progress in Neurobiology.

[50]  G. Schellenberg,et al.  Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease , 1998, Neurology.

[51]  D. Dorsa,et al.  Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus , 1993, Brain Research.

[52]  F. Jiménez-Jiménez,et al.  Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease , 2000, Journal of Neural Transmission.

[53]  D. Porte,et al.  Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. , 1987, The Journal of clinical endocrinology and metabolism.

[54]  D. S. Zahm,et al.  Insulin gene expression and insulin synthesis in mammalian neuronal cells. , 1994, The Journal of biological chemistry.

[55]  B. McEwen,et al.  Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. Posner,et al.  Insulin-degrading enzyme. , 1996, Clinical and investigative medicine. Medecine clinique et experimentale.

[57]  D. Alkon,et al.  Role of insulin and insulin receptor in learning and memory , 2001, Molecular and Cellular Endocrinology.

[58]  B. Wainer,et al.  Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines 1 Presented in part at the Society for Pediatric Research held at Seattle, WA, USA in May, 1994. 1 , 1997, Regulatory Peptides.

[59]  K Yaffe,et al.  Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. , 2000, Archives of internal medicine.

[60]  A. McCall,et al.  Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study , 1996, Brain Research.

[61]  R. Schechter,et al.  Insulin synthesis by isolated rabbit neurons. , 1988, Endocrinology.

[62]  D. Accili,et al.  Signalling through IGF-I and insulin receptors: where is the specificity? , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[63]  Sironi,et al.  Insulin: new roles for an ancient hormone , 1999, European journal of clinical investigation.

[64]  S. Woods,et al.  Insulin in the brain. , 1987, Annual review of physiology.

[65]  F. Jiménez-Jiménez,et al.  Serum levels of coenzyme Q10 in patients with Parkinson's disease , 2000, Journal of Neural Transmission.

[66]  L. Pénicaud,et al.  Immunocytochemical localization of the insulin‐responsive glucose transporter 4 (Glut4) in the rat central nervous system , 1998, The Journal of comparative neurology.

[67]  P. Dandona.  Endothelium, inflammation, and diabetes , 2002, Current diabetes reports.

[68]  Sanjay Asthana,et al.  Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender , 1999, Neuroendocrinology.

[69]  I. Deary,et al.  Is Type II Diabetes Associated With an Increased Risk of Cognitive Dysfunction?: A critical review of published studies , 1997, Diabetes Care.

[70]  K. Akiyama,et al.  Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type , 1991, Biological Psychiatry.

[71]  T. Pagano,et al.  Insulin receptors and insulin action in the brain: review and clinical implications , 2000, Neuroscience & Biobehavioral Reviews.

[72]  P. Mueller,et al.  Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa , 1971, Clinical pharmacology and therapeutics.

[73]  M. Laakso,et al.  Cognitive Function in an Elderly Population With Persistent Impaired Glucose Tolerance , 1998, Diabetes Care.

[74]  J. Born,et al.  Improving Influence of Insulin on Cognitive Functions in Humans , 2001, Neuroendocrinology.

[75]  S. Nicolaidis,et al.  Basal and hyperinsulinemia-induced immunoreactive hypothalamic insulin changes in lean and genetically obese Zucker rats revealed by microdialysis , 1993, Brain Research.

[76]  I. Lipman,et al.  Glucose intolerance in Parkinson's disease. , 1974, Journal of Chronic Diseases.

[77]  J. Newcomer,et al.  Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. , 1999, Archives of general psychiatry.

[78]  C Cobelli,et al.  Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. , 1993, The Journal of clinical investigation.

[79]  R. Balázs,et al.  β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised* , 2001, The Journal of Biological Chemistry.

[80]  J. Born,et al.  Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology? , 2000, European journal of pharmacology.

[81]  W. Banks,et al.  Selective, Physiological Transport of Insulin Across the Blood-Brain Barrier: Novel Demonstration by Species-Specific Radioimmunoassays , 1997, Peptides.

[82]  B. Wolf,et al.  Differential effects of proteases involved in intracellular degradation of amyloid beta-protein between detergent-soluble and -insoluble pools in CHO-695 cells. , 2002, Biochemistry.

[83]  P. Marsden,et al.  The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. , 2002, Diabetes.

[84]  S. Asthana,et al.  Insulin increases CSF Aβ42 levels in normal older adults , 2003, Neurology.

[85]  D. Singer,et al.  Decreased cognitive function in aging non-insulin-dependent diabetic patients. , 1984, The American journal of medicine.

[86]  R. Duara,et al.  Confirmation of association between D10S583 and Alzheimer's disease in a case–control sample , 2002, Neuroscience Letters.

[87]  J. Clore,et al.  Increased Transcapillary Escape Rate of Albumin in Nondiabetic Men in Response to Hyperinsulinemia , 1990, Diabetes.

[88]  I. Kopin,et al.  Dopamine receptor binding is increased in diabetic rats. , 1981, Science.

[89]  M. Tatar,et al.  The Endocrine Regulation of Aging by Insulin-like Signals , 2003, Science.

[90]  T. Gómez-Isla,et al.  Serum insulin-like growth factor I regulates brain amyloid-β levels , 2002, Nature Medicine.

[91]  R. Kalaria.  The role of cerebral ischemia in Alzheimer’s disease , 2000, Neurobiology of Aging.

[92]  L. Hersh,et al.  Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.

[93]  C. Haass,et al.  Insulin-degrading Enzyme Rapidly Removes the β-Amyloid Precursor Protein Intracellular Domain (AICD)* , 2002, The Journal of Biological Chemistry.

[94]  B. Jeanrenaud,et al.  Four-day hyperinsulinemia in euglycemic conditions alters local cerebral glucose utilization in specific brain nuclei of freely moving rats , 1995, Brain Research.

[95]  M. Hurlbert,et al.  Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. , 1999, Diabetes.

[96]  C. Brayne,et al.  Vascular Risks and Incident Dementia: Results from a Cohort Study of the Very Old , 1998, Dementia and Geriatric Cognitive Disorders.

[97]  L. Pénicaud,et al.  Altered conditioned taste aversion and glucose utilization in related brain nuclei of diabetic GK rats , 1995, Brain Research Bulletin.

[98]  M. Brownstein,et al.  Identification of insulin in rat brain. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[99]  V. V. Zinoviev,et al.  Bacteriophage T4 Dam DNA-[N6-adenine]Methyltransferase , 2002, The Journal of Biological Chemistry.

[100]  A. Belfiore,et al.  Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved* , 2002, The Journal of Biological Chemistry.

[101]  G. Schellenberg,et al.  Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele , 2003 .

[102]  P. Greengard,et al.  Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling , 2001, The Journal of Neuroscience.

[103]  J. Meigs.  Epidemiology of the insulin resistance syndrome , 2003, Current diabetes reports.

[104]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[105]  H. Bozdemir,et al.  Vascular parkinsonism: a distinct, heterogeneous clinical entity , 2001, Acta neurologica Scandinavica.

[106]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[107]  M. Brownstein,et al.  Insulin receptors are widely distributed in the central nervous system of the rat , 1978, Nature.

[108]  D. Alkon,et al.  Brain Insulin Receptors and Spatial Memory , 1999, The Journal of Biological Chemistry.

[109]  K. Hirayama,et al.  Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease , 1994, Acta Neuropathologica.

[110]  S. Woods,et al.  Intracerebroventricular insulin enhances memory in a passive-avoidance task , 2000, Physiology & Behavior.

[111]  Y. Sheline,et al.  Memory improvement following induced hyperinsulinemia in alzheimer's disease , 1996, Neurobiology of Aging.

[112]  M. Abbott,et al.  The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses , 1999, The Journal of Neuroscience.

[113]  K. Marder,et al.  Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study , 2002, Movement disorders : official journal of the Movement Disorder Society.

[114]  K. Jellinger.  Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study , 2003, Acta Neuropathologica.

[115]  H. Lebovitz,et al.  Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-Dopa. , 1971, The Journal of clinical endocrinology and metabolism.

[116]  R. L. Rogers,et al.  Aetiological considerations and risk factors for multi-infarct dementia. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[117]  Patrick R Hof,et al.  Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[118]  I. Kurochkin,et al.  Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme , 1994, FEBS letters.

[119]  A. Cincotta,et al.  Intracerebroventricular Administration of Bromocriptine Ameliorates the Insulin-Resistant/Glucose-Intolerant State in Hamsters , 1999, Neuroendocrinology.

[120]  Matthew P. Frosch,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[121]  R. Schwab.  PROGRESSION AND PROGNOSIS IN PARKINSON'S DISEASE , 1960, The Journal of nervous and mental disease.

[122]  M. Owen,et al.  Susceptibility locus for Alzheimer's disease on chromosome 10. , 2000, Science.

[123]  C. Baratti,et al.  Effects of Posttraining Administration of Glucose on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism , 1996, Neurobiology of Learning and Memory.

[124]  R. Cooper,et al.  Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. , 2002, American journal of physiology. Endocrinology and metabolism.

[125]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[126]  Ole A. Andreassen,et al.  Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression , 2002, Neurobiology of Disease.

[127]  D. Bennett,et al.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. , 2004, Archives of neurology.

[128]  R. Mayeux,et al.  The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism , 2003, Neurology.

[129]  S. Podolsky,et al.  Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease. , 1977, Gerontology.

[130]  O B Paulson,et al.  No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. , 1999, Diabetes.

[131]  L. Farrer.  Diabetes mellitus in Huntington disease , 1985, Clinical genetics.

[132]  D. Campion,et al.  Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease , 2002, Neuroscience Letters.

[133]  Patrick L. McGeer,et al.  Inflammation, autotoxicity and Alzheimer disease , 2001, Neurobiology of Aging.

[134]  J. Mcdermott,et al.  Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme , 2004, Neurochemical Research.

[135]  D. Leroith,et al.  Insulin and Insulin-Like Growth Factor I Receptors: Similarities and Differences in Signal Transduction , 2004, Hormone Research in Paediatrics.

[136]  E. Kokmen,et al.  The risk of dementia among persons with diabetes mellitus: a population-based cohort study. , 1997 .

[137]  D. Cui,et al.  Peptide derived from insulin with regulatory activity of dopamine transporter , 2001, Neuropharmacology.

[138]  G. Winocur,et al.  Glucose Treatment Reduces Memory Deficits in Young Adult Rats Fed High-Fat Diets , 2001, Neurobiology of Learning and Memory.

[139]  S. Lovestone,et al.  Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[140]  M. Laakso,et al.  Essential hypertension and cognitive function. The role of hyperinsulinemia. , 1993, Hypertension.

[141]  J. Blangero,et al.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.

[142]  T. Harris,et al.  Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance , 1999, Neurology.

[143]  C. Baratti,et al.  Effects of Posttraining Administration of Insulin on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism , 1999, Neurobiology of Learning and Memory.

[144]  E. Tangalos,et al.  Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE) , 2003, Neuroscience Letters.

[145]  W. Banks,et al.  Transport of Insulin Across the Blood-Brain Barrier: Saturability at Euglycemic Doses of Insulin , 1997, Peptides.

[146]  W. Jagust,et al.  Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. , 2000, Archives of neurology.

[147]  J. Sutcliffe,et al.  Insulin receptor substrate protein p53 localization in rats suggests mechanism for specific polyglutamine neurodegeneration , 2001, Neuroscience Letters.